Neuronetics Inc (STIM)

Overview Chart Financials Statistics Earnings Insider transactions ETFs News

News

Real-time news feed aggregating press releases, regulatory filings, and global media coverage for a single company, filterable by date range, relevance score, and sentiment classification. Each article is tagged with company-specific and overall market sentiment — allowing investors to separate fundamental catalysts from broader market noise and monitor how the narrative around a stock is evolving over time.

Oct 27, 2026

Neuronetics Sets November 4 Earnings Report Amid Clinic Expansion

Neuronetics Inc. (Nasdaq: STIM) is set to report its third-quarter 2026 financial results on November 4, covering its medical technology and psychiatric treatment business, including NeuroStar magnetic stimulation systems and the Greenbrook clinic network. The company will release results before U.S. financial markets open, followed by a management conference call. Neuronetics specializes in transcranial magnetic stimulation (TMS) technology and operates a network of psychiatric treatment centers.